Kortikosteroid ile İndüklenen Hipokalemik Periyodik Paralizi: İki Olgu Sunumu

Year 2016, Volume: 69 Issue: 3, 211 - 212, 31.12.2016

Ferda Selçuk Senem Mut

Abstract

Hipokalemik periyodik paralizi (HPP) oldukça nadir görülen, kollarda ve bacaklarda ani gelişen yaygın kas kuvvetsizliği ile seyreden bir hastalıktır. Her iki olgumuzda kortikosteroid enjeksiyonu sonrası gelişen ani yaygın kas kuvvetsizliği 10 saat içerisinde kendiliğinden düzelmişti. Acil rutin kan tetkiklerinde serum potasyum seviyesi belirgin düşük saptandı. Her iki olgunun uygulanan potasyum replasmanı tedavisi sonrası klinikleri tam düzeldi. Ani gelişen kas kuvvetsizliği ile başvuran hastalarda nadir de olsa HPP’nin akılda bulundurulması önerilmektedir.

Keywords

Periyodik Paralizi , Hipokalemi , Kortikosteroid

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

Kortikosteroid ile İndüklenen Hipokalemik Periyodik Paralizi

Abstract

Hypokalemic periodic paralysis (HPP) is a rare disorder characterised by acute weakness of the upper and lower limbs. We present two cases who developed generalized weakness after corticosteroid injection and totally recovered after 10 hours. The blood tests of the cases revealed hypopotassemia and after replacement treatment they clinically recovered. We intended to present the cases to point out that HPP must be kept in mind in patients applying to the emergency with acute onset of muscle weakness.

Keywords

Periodic Paralysis , Hypokalemia , Corticosteroid

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

• 1. Oran M, Bilir B, Şakacı M. ve ark. Hipokalemik periyodik paralizi olgusu. IAAOJ, Health Science 2014: 2; 7-10.
• 2. Adaş C, Utku U, Utku B ve ark.., Hipokalemik periyodik paralizi olgusu. J Kartal TR 2014; 25: 233-234.
• 3. Fontaine B, Fournier E, Sternberg D et al..Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder. Neurotherapeutics. 2007; 4:225-232.
• 4. Kelley DE, Gharib H, Kennedy FP. et al. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989;149:2597- 2600.
• 5. Wessel K, Schumm F, Peiffer J et al. Hypokalemic periodic paralysis provoked by "Ambene"Nervenarzt. 1985;56:696-702.
• 6. Miyashita Y, Monden T, Yamamoto K, et al. Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis. Intern Med. 2006;45:11-13.
• 7. Liu Z, Braverman LE, Malabanan A.Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocr Pract. 2006;12:427-431.
• 8. Wongraoprasert S, Buranasupkajorn P, Sridama V, et al. Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern Med. 2007;46:1431-1433.
• 9. Tamez-Pérez HE, Cisneros-Pérez V, Cedillo- Rodríguez JA et al. [Prevalence of hypokalemia in patients with methylprednisolone pulse therapy] Rev Invest Clin. 2009;61:194-197.
• 10. Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006;91:2490-2495.
• 11. Clausen T. Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev. 2003;83:1269-1324.
• 12. Ryan DP, da Silva MR, Soong TW,et al.Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell. 2010 8;140:18.